Harry Heijerman

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.3K citations · Full text

Mendelian Disorder, Genetics, Ivacaftor Combination Regimen +2

Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis

Johanna F. Dekkers, Gitte Berkers, Evelien Kruisselbrink et al. · Science Translational Medicine · 2016 · 539 citations

Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis

Gitte Berkers, Peter van Mourik, Annelotte M. Vonk et al. · Cell Reports · 2019 · 300 citations · Full text

A Cystic Fibrosis Mutation Associated with Mild Lung Disease

K. H. Gan, Henk J. Veeze, Ans van den Ouweland et al. · New England Journal of Medicine · 1995 · 177 citations · Full text

Can helical CT replace scintigraphy in the diagnostic process in suspected pulmonary embolism? A retrolective-prolective cohort study focusing on total diagnostic yield

A. B. van Rossum, Peter M. T. Pattynama, W. M. C. Mallens et al. · European Radiology · 1998 · 123 citations

Pulmonary Embolism, Diagnostic Process, Medical Imaging +10